医学
奥沙利铂
卡培他滨
阶段(地层学)
肿瘤科
结直肠癌
化疗
内科学
中止
比例危险模型
癌症
危险系数
胃肠病学
外科
置信区间
古生物学
生物
作者
Claire Gallois,Qian Shi,Levi D. Pederson,Thierry André,Timothy Iveson,Alberto F. Sobrero,Steven R. Alberts,Aimery de Gramont,Jeffrey A. Meyerhardt,Thomas J. George,Hans‐Joachim Schmoll,Ioannis Souglakos,Andrea Harkin,Roberto Labianca,Frank A. Sinicrope,Eiji Oki,Anthony F. Shields,Ioannis Boukovinas,Rachel Kerr,Sara Lonardi
摘要
A number of studies suggest that older patients may have reduced or no benefit from the addition of oxaliplatin to fluoropyrimidines as adjuvant chemotherapy for stage III colon cancer (CC).
科研通智能强力驱动
Strongly Powered by AbleSci AI